Changes in Postpartum Insulin Requirements for Patients with Well-Controlled Type 1 Diabetes

Hilary A Roeder1, Thomas R Moore1, Gladys A Ramos1

  • 1Division of Perinatology, Department of Reproductive Medicine, UC San Diego Health, San Diego, California.

Insights

Postpartum insulin needs for women with type 1 diabetes mellitus (T1DM) significantly decrease compared to preconception levels. Infant feeding method and insulin delivery type did not impact these reduced postpartum insulin doses.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Maternal-Fetal Medicine

Background:

  • Type 1 diabetes mellitus (T1DM) requires careful insulin management throughout pregnancy.
  • Postpartum metabolic changes can significantly alter insulin requirements in women with T1DM.
  • Understanding postpartum insulin needs is crucial for safe and effective diabetes management after delivery.

Purpose of the Study:

  • To compare preconception and postpartum total daily insulin (TDI) doses in well-controlled T1DM.
  • To investigate the influence of infant feeding methods on postpartum insulin requirements.
  • To assess differences in postpartum insulin dosing based on insulin administration route (CSII vs. MDI).

Main Methods:

  • Retrospective cohort study of 44 women with T1DM and HbA1c ≤ 7.4%.
  • Comparison of preconception and postpartum total daily insulin (TDI) doses.
  • Abstraction of data on insulin administration method, HbA1c, BMI, and infant feeding practices.

Main Results:

  • A significant 34% decrease in postpartum TDI compared to preconception TDI was observed (p=0.02).
  • No significant differences in postpartum TDI were found between breastfed and formula-fed infants.
  • Insulin administration route (CSII vs. MDI) did not impact postpartum TDI.

Conclusions:

  • Women with T1DM require substantially less insulin postpartum compared to preconception.
  • Postpartum insulin dosage adjustments are necessary and appear independent of infant feeding method or insulin delivery system.
  • These findings support a re-evaluation of postpartum insulin dosing strategies in T1DM patients.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.0K